Screening and Brief Intervention for Cannabis Misuse in Individuals on Buprenorphine Treatment for Opioid Use Disorder: Double-Blind Randomized Clinical Trial

References

• Bahji, A., and C. Stephenson. 2019. International perspectives on the implications of cannabis legalization: A systematic review & thematic analysis. International Journal of Environmental Research and Public Health 16 (17):3095. doi:10.3390/ijerph16173095.
   PubMed Web of Science ®Google Scholar
• Basu, D., A. Ghosh, B. N. Subodh, and S. K. Mattoo. 2020. Opioid substitution therapy with buprenorphine-naloxone during COVID-19 outbreak in India: Sharing our experience and interim standard operating procedure. Indian Journal of Psychiatry 62 (3):322–26. doi:10.4103/psychiatry.IndianJPsychiatry_295_20.
   PubMed Web of Science ®Google Scholar
• Borsari, B., J. G. Murphy, and K. B. Carey. 2009. Readiness to change in brief motivational interventions: A requisite condition for drinking reductions? Addictive Behaviors 34:232–35. doi:10.1016/j.addbeh.2008.10.010.
   PubMed Web of Science ®Google Scholar
• Choi, J., J. Chung, and J. Choi. 2021. Exploring impact of Marijuana (Cannabis) abuse on adults using machine learning. International Journal of Environmental Research and Public Health 18 (19):10357. doi:10.3390/ijerph181910357.
   PubMed Web of Science ®Google Scholar
• Darker, C. D., B. P. Sweeney, H. O. El Hassan, B. P. Smyth, J. H. Ivers, and J. M. Barry. 2012. Brief interventions are effective in reducing alcohol consumption in opiate-dependent methadone-maintained patients: Results from an implementation study. Drug and Alcohol Review 31 (3):348–56. doi:10.1111/j.1465-3362.2011.00349.x.
   PubMed Web of Science ®Google Scholar
• Darker, C. D., B. Sweeney, E. Keenan, L. Whiston, R. Anderson, and J. Barry. 2016. Screening and brief interventions for illicit drug use and alcohol use in methadone maintained opiate-dependent patients: Results of a pilot cluster randomized controlled trial feasibility study. Substance Use & Misuse 51 (9):1104–15. doi:10.3109/10826084.2016.1160118.
   PubMed Web of Science ®Google Scholar
• De Aquino, J. P., M. Sofuoglu, E. Stefanovics, and R. Rosenheck. 2019. Adverse consequences of co-occurring opioid use disorder and cannabis use disorder compared to opioid use disorder only. The American Journal of Drug and Alcohol Abuse 45 (5):527–37. doi:10.1080/00952990.2019.1607363.
   PubMed Web of Science ®Google Scholar
• Fischer, B., T. Robinson, C. Bullen, V. Curran, D. Jutras-Aswad, M. E. Medina-Mora, R. L. Pacula, J. Rehm, R. Room, W. van den Brink, et al. 2022. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. The International Journal on Drug Policy 99:103381. doi:10.1016/j.drugpo.2021.103381.
   PubMed Web of Science ®Google Scholar
• Gorfinkel, L. R., M. Stohl, E. Greenstein, E. Aharonovich, M. Olfson, and D. Hasin. 2021. Is cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis. Addiction (Abingdon, England) 116 (5):1113–21. doi:10.1111/add.15228.
   PubMed Web of Science ®Google Scholar
• Hadland, S. E., and S. Levy. 2016. Objective testing: Urine and other drug tests. Child and Adolescent Psychiatric Clinics of North America 25 (3):549–65. doi:10.1016/j.chc.2016.02.005.
   PubMed Web of Science ®Google Scholar
• Hayley, A. C., C. Stough, and L. A. Downey. 2017. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 27 (8):732–43. doi:10.1016/j.euroneuro.2017.06.004.
   PubMed Web of Science ®Google Scholar
• Humeniuk, R., R. Ali, T. Babor, M. L. Souza-Formigoni, R. B. de Lacerda, W. Ling, B. McRee, D. Newcombe, H. Pal, V. Poznyak, et al. 2012. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction (Abingdon, England) 107 (5):957–66. doi:10.1111/j.1360-0443.2011.03740.x.
   PubMed Web of Science ®Google Scholar
• Humeniuk, R. E., S. Henry-Edwards, R. L. Ali, and S. Meena. 2010b. Self-help strategies for cutting down or stopping substance use: A guide. Geneva: World Health Organization.
   Google Scholar
• Humeniuk, R., S. Henry-Edwards, R. Ali, V. Poznyak, and M. G. Monteiro, World Health Organization. 2010a. The ASSIST-linked brief intervention for hazardous and harmful substance use: A manual for use in primary care. Geneva. Accessed: https://www.who.int/publications/i/item/the-assist-linked-brief-intervention-for-hazardous-and-harmful-substance-use.
   Google Scholar
• Imtiaz, S., M. Roerecke, P. Kurdyak, A. V. Samokhvalov, O. Hasan, and J. Rehm. 2020. Brief interventions for cannabis use in healthcare settings: Systematic review and meta-analyses of randomized trials. Journal of Addiction Medicine 14 (1):78–88. doi:10.1097/ADM.0000000000000527.
   PubMed Web of Science ®Google Scholar
• Maisto, S. A., J. Conigliaro, M. McNeil, K. Kraemer, R. L. Conigliaro, and M. E. Kelley. 2001. Effects of two types of brief intervention and readiness to change on alcohol use in hazardous drinkers. Journal of Studies on Alcohol 62:605–14. doi:10.15288/jsa.2001.62.605.
   PubMed Web of Science ®Google Scholar
• Morisky, D. E., A. Ang, M. Krousel-Wood, and H. J. Ward. 2008. Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertension (Greenwich, Conn.) 10 (5):348–54. doi:10.1111/j.1751-7176.2008.07572.x.
   PubMed Web of Science ®Google Scholar
• Norberg, M. M., J. Mackenzie, and J. Copeland. 2012. Quantifying cannabis use with the timeline followback approach: A psychometric evaluation. Drug and Alcohol Dependence 121 (3):247–52. doi:10.1016/j.drugalcdep.2011.09.007.
   PubMed Web of Science ®Google Scholar
• Onaemo, V. N., T. O. Fawehinmi, and C. D’Arcy. 2021. Comorbid cannabis use disorder with major depression and generalized anxiety disorder: A systematic review with meta-analysis of nationally representative epidemiological surveys. Journal of Affective Disorders 281:467–75. doi:10.1016/j.jad.2020.12.043.
   PubMed Web of Science ®Google Scholar
• Saitz, R. 2014. Screening and brief intervention for unhealthy drug use: Little or no efficacy. Frontiers in Psychiatry 5:121. doi:10.3389/fpsyt.2014.00121.
   PubMed Web of Science ®Google Scholar
• Shulman, M., J. M. Wai, and E. V. Nunes. 2019. Buprenorphine treatment for opioid use disorder: An overview. CNS Drugs 33 (6):567–80. doi:10.1007/s40263-019-00637-z.
   PubMed Web of Science ®Google Scholar
• Sinha, A., A. Kohli, A. Ghosh, and D. Basu. 2022. Efficacy of screening and brief intervention for hazardous alcohol use in patients with mood disorders: A randomized clinical trial from a psychiatric out-patient clinic in India. Asian Journal of Psychiatry 73:103138. doi:10.1016/j.ajp.2022.103138.
   PubMed Web of Science ®Google Scholar
• Solberg, L. I., M. V. Maciosek, and N. M. Edwards. 2008. Primary care intervention to reduce alcohol misuse ranking its health impact and cost effectiveness. American Journal of Preventive Medicine 34 (2):143–52. doi:10.1016/j.amepre.2007.09.035.
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., R. D. Baler, W. M. Compton, and S. R. Weiss. 2014. Adverse health effects of marijuana use. The New England Journal of Medicine 370 (23):2219–27. doi:10.1056/NEJMra1402309.
   PubMed Web of Science ®Google Scholar
• WHO ASSIST Working Group. 2002. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development, reliability and feasibility. Addiction (Abingdon, England) 97 (9):1183–94. doi:10.1046/j.1360-0443.2002.00185.x.
   PubMed Web of Science ®Google Scholar
• World Drug Report. 2021. United Nations office of drugs and crime. Vienna. Accessed March 10th, 2022. https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html
   Google Scholar